Does GIVOSIRAN Cause Product dose omission issue? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Product dose omission issue have been filed in association with GIVOSIRAN (GIVLAARI). This represents 6.9% of all adverse event reports for GIVOSIRAN.
85
Reports of Product dose omission issue with GIVOSIRAN
6.9%
of all GIVOSIRAN reports
2
Deaths
60
Hospitalizations
How Dangerous Is Product dose omission issue From GIVOSIRAN?
Of the 85 reports, 2 (2.4%) resulted in death, 60 (70.6%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GIVOSIRAN. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does GIVOSIRAN Cause?
Porphyria acute (381)
Hospitalisation (141)
Nausea (91)
Fatigue (84)
Therapy interrupted (83)
Pain (74)
Intentional dose omission (63)
Abdominal pain (62)
Vomiting (58)
Malaise (56)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which GIVOSIRAN Alternatives Have Lower Product dose omission issue Risk?
GIVOSIRAN vs GLASDEGIB
GIVOSIRAN vs GLATIRAMER
GIVOSIRAN vs GLECAPREVIR\PIBRENTASVIR
GIVOSIRAN vs GLEEVEC
GIVOSIRAN vs GLICLAZIDE